An infrared spectral biomarker accurately predicts neurodegenerative disease class in the absence of overt symptoms
Abstract Although some neurodegenerative diseases can be identified by behavioral characteristics relatively late in disease progression, we currently lack methods to predict who has developed disease before the onset of symptoms, when onset will occur, or the outcome of therapeutics. New biomarkers...
Guardado en:
Autores principales: | Lila Lovergne, Dhruba Ghosh, Renaud Schuck, Aris A. Polyzos, Andrew D. Chen, Michael C. Martin, Edward S. Barnard, James B. Brown, Cynthia T. McMurray |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/846890e2041e4915b5b464f2f470d9da |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs
por: Roggeri DP, et al.
Publicado: (2015) -
Insights into the evolutionary features of human neurodegenerative diseases.
por: Arup Panda, et al.
Publicado: (2012) -
Plasmonic piezoelectric nanomechanical resonator for spectrally selective infrared sensing
por: Yu Hui, et al.
Publicado: (2016) -
Spectral clustering using Nyström approximation for the accurate identification of cancer molecular subtypes
por: Mingguang Shi, et al.
Publicado: (2017) -
Resting Whole Body Energy Metabolism in Class 3 Obesity; from Preserved Insulin Sensitivity to Overt Type 2 Diabetes
por: Manzoni G, et al.
Publicado: (2020)